← All patents

US10870854B2

Inhibitory RNA-based therapeutics targeting ANLN for cancer treatment

University of Texas System

Abstract

Embodiments of the present disclosure include compositions and methods related to certain siRNA compositions for the treatment of cancer. In specific embodiments, siRNAs are employed for treatment of cancer, including at least liver cancer. Therapeutic methods, compositions, and kits are …

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Hao Zhu
Priority date
June 09, 2016
Filing date
May 24, 2017
Grant date
December 22, 2020
Publication date
December 22, 2020
Language
en
Metadata fetched
August 29, 2026 00:27